| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 09/16/2004 | CA2517145A1 Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 09/16/2004 | CA2516098A1 Oxytocin controlled release formulations and methods of using same |
| 09/16/2004 | CA2516078A1 Catechol compositions and use thereof |
| 09/16/2004 | CA2515098A1 Invisible patch for active agent controlled delivery |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1456647A2 Methods for identifying and validating potential drug targets--- |
| 09/15/2004 | EP1456398A2 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna and use of recombinant hpivi in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 09/15/2004 | EP1456376A2 Novel chimeric rev, tat, and nef antigens |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1455858A2 Catheter composition and uses thereof |
| 09/15/2004 | EP1455840A2 Treatment of human cancer with adenoviral vector expressing tnf-alpha |
| 09/15/2004 | EP1455810A1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 09/15/2004 | EP1455786A1 Use of a compound in the treatment of sleep disorders and the like in providing refreshedness on waking and a method for the treatment of grogginess therewith |
| 09/15/2004 | EP1455756A1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 09/15/2004 | EP1339420B1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 09/15/2004 | EP1246638B1 Use of exendins and agonists thereof for the treatment of hypertriglyceridemia |
| 09/15/2004 | EP1173210B1 Contraceptive compositions containing antiprogestinic and progestinic |
| 09/15/2004 | CN1529616A Vaccine formulation potentiated by combination of DNA and an antigen |
| 09/15/2004 | CN1529598A Method of treating demyelinating diseases or conditions |
| 09/15/2004 | CN1166668C Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
| 09/15/2004 | CN1166640C Substituted 1,2,3,4,5,6-hyxahydro-2,6-methano-3-benzazocine-10-oles, method for production and use thereof as medicaments |
| 09/15/2004 | CN1166365C Alendronic-acid medicind composition and use of same for preparing medictne for inhibiting bone resorption of humanbody |
| 09/15/2004 | CN1166364C Controlled drug delivery system for diltiazem |
| 09/14/2004 | US6790850 Thiazolo(4,5-d)pyrimidine compounds |
| 09/14/2004 | CA2116829C Use of a pregnane derivative |
| 09/10/2004 | WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | WO2004076410A2 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/10/2004 | WO2004075863A2 Cxcr3 antagonists |
| 09/10/2004 | WO2004075862A2 Crosslinkable polymeric materials and their applications |
| 09/10/2004 | WO2004075860A2 Process for purification of zoledronic acid |
| 09/10/2004 | WO2004075859A2 Treatment of canine hemangiosarcoma with a histone deacetylase inhibitor |
| 09/10/2004 | WO2004075855A2 Process for in vivo treatment of specific biological targets in bodily fluid |
| 09/10/2004 | WO2004075854A2 Microbicidal compositions and method of use |
| 09/10/2004 | WO2004075853A2 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 09/10/2004 | WO2004075850A2 Polyvalent immunogen |
| 09/10/2004 | WO2004075848A2 Antitumor inhibitors and use thereof |
| 09/10/2004 | WO2004075846A2 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| 09/10/2004 | WO2004075845A2 Methods for treating or preventing autoimmune disease using histamine h1 receptor-blocking agents |
| 09/10/2004 | WO2004075843A2 Glycosolated enkephalin agents |
| 09/10/2004 | WO2004075842A2 Mrp3 genes and uses thereof |
| 09/10/2004 | WO2004075840A2 Selective non-steroidal glucocorticoid receptor modulators |
| 09/10/2004 | WO2004075839A2 Methods and compositions for modulating apoptosis |
| 09/10/2004 | WO2004075838A2 Method and compositions for the treatment of meconium aspiration syndrome |
| 09/10/2004 | WO2004075835A2 Methods for the treatment of renal cell carcinoma |
| 09/10/2004 | WO2004075834A2 Stabilized pharmaceutical compositions of safingol and methods of using the same |
| 09/10/2004 | WO2004075831A2 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues |
| 09/10/2004 | WO2004075830A2 Knockout identification of target-specific sites in peptides |
| 09/10/2004 | WO2004075827A2 Process for the preparation of 2-[(diphenylmethyl) thio] acetamide |
| 09/10/2004 | WO2004075826A2 Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation |
| 09/10/2004 | WO2004075825A2 Dosage forms of amlodipine and processes for their preparation |
| 09/10/2004 | WO2004075815A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | WO2004075811A2 Subcutaneously-administered ganglioside-based vaccine compositions |
| 09/10/2004 | WO2004060263A3 Magnesium salt of imidazole derivative |
| 09/10/2004 | WO2004058803A3 Peptides that bind of the vegfr-2 |
| 09/10/2004 | WO2004058175A3 Novel use of liver x receptor agonists |
| 09/10/2004 | WO2004052281A3 Oral lactoferrin in the treatment of sepsis |
| 09/10/2004 | WO2004050010A3 Composition, especially a cosmetic composition, containing at least one alkyl para-hydroxybenzoate and at least one lipophilic amino acid derivative |
| 09/10/2004 | WO2004041211A3 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT |
| 09/10/2004 | WO2004037208A3 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
| 09/10/2004 | WO2004034985A3 Chemical compounds |
| 09/10/2004 | WO2004030622A3 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 09/10/2004 | WO2004019886A3 Methods for up-regulating antigen expression in tumors |
| 09/10/2004 | WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 09/10/2004 | CA2517387A1 Process for purification of zoledronic acid |
| 09/10/2004 | CA2517346A1 Treatment of canine hemangiosarcoma with a histone deacetylase inhibitor |
| 09/10/2004 | CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | CA2517052A1 Polyvalent immunogen |
| 09/10/2004 | CA2516900A1 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/10/2004 | CA2516750A1 Knockout identification of target-specific sites in peptides |
| 09/10/2004 | CA2516684A1 Selective non-steroidal glucocorticoid receptor modulators |
| 09/10/2004 | CA2516573A1 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 09/10/2004 | CA2516399A1 Pharmaceutical compositions of safingol and methods of using the same |
| 09/10/2004 | CA2515842A1 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 09/10/2004 | CA2515129A1 Pharmacodynamic assay for inhibitors of 11-beta-hydroxysteroid dehydrogenase activity in animal tissues |
| 09/10/2004 | CA2514900A1 Process for the preparation of 2-[(diphenylmethyl) thio] acetamide |
| 09/10/2004 | CA2514430A1 Crosslinkable polymeric materials and their applications |
| 09/10/2004 | CA2514329A1 Methods for the treatment of renal cell carcinoma |
| 09/10/2004 | CA2507527A1 Glycosolated enkephalin agents |
| 09/09/2004 | US20040177387 Using mutation in gene associated with monocyte chemoattractant protein-1detect, diagnose, prevent and treat vision disorders |
| 09/09/2004 | US20040176615 Forming calcium salt from ester |
| 09/09/2004 | US20040176575 Compounds comprising modified secondary ligand binding site for treatment and prevention of infections, diabetes, emphysema, viral, endocrine and cell proliferative disorders |
| 09/09/2004 | US20040176463 Immediate release formulation of n-(2-propylpentanoyl)glycinamide |
| 09/09/2004 | US20040176462 NPY Y5 antagonist |
| 09/09/2004 | US20040176425 Cycloalkyl containing anilide ligands for the thyroid receptor |
| 09/09/2004 | US20040176414 principle metabolite of cisapride; has both 5-HT3 antagonistic and 5-HT4 agonistic; devoid of central nervous system effects; separating racemic mixture by liquid chromatography over a chiral stationary phase |
| 09/09/2004 | US20040176357 Stable, amorphous , lyophilized, parenteral injections comprising olanzapine, solubilizer and stabilizer; bipolar, psychological and neurodegenerative disorders; anxiolytic agents;schizophrenia |
| 09/09/2004 | US20040176335 Novel cocrystallization |
| 09/09/2004 | US20040176327 Use of bisphosphonic acids for treating angiogenesis |
| 09/09/2004 | US20040176325 P38 MAP kinase inhibitors comprising indazole derivatives; antiinflammatory and antiproliferative agents; autoimmune, bone, and neurodegenerative disorders; viricides, infections |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040176276 Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
| 09/09/2004 | US20040175731 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides |
| 09/09/2004 | US20040175727 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells |
| 09/08/2004 | EP1453837A2 Targeted therapeutics and uses thereof |
| 09/08/2004 | EP1453520A1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 09/08/2004 | EP1453505A2 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 09/08/2004 | EP1453487A1 Pharmaceutical dosage form with multiple coatings |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | EP1047387B1 Dyeing composition for keratinous fibres with direct cationic colouring agent and a quaternary ammonium salt |
| 09/08/2004 | CN1527816A New indole derivatives with 5-HT6 receptor affinity |